Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.17 USD | -2.69% | -12.80% | +127.38% |
May. 15 | Cullinan Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 15 | Cullinan Therapeutics, Inc. Announces Board Changes | CI |
Financials (USD)
Sales 2024 * | 1.88M | Sales 2025 * | 11.59M | Capitalization | 1.34B |
---|---|---|---|---|---|
Net income 2024 * | -165M | Net income 2025 * | -189M | EV / Sales 2024 * | 375 x |
Net cash position 2024 * | 632M | Net cash position 2025 * | 559M | EV / Sales 2025 * | 67 x |
P/E ratio 2024 * |
-7.7
x | P/E ratio 2025 * |
-7.49
x | Employees | 85 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.22% |
Latest transcript on Cullinan Therapeutics, Inc.
1 day | -2.69% | ||
1 week | -12.80% | ||
Current month | -14.22% | ||
1 month | +28.29% | ||
3 months | +27.10% | ||
6 months | +163.30% | ||
Current year | +127.38% |
Managers | Title | Age | Since |
---|---|---|---|
Nadim Ahmed
CEO | Chief Executive Officer | 56 | 21-10-17 |
Jeffrey Jones
CTO | Chief Tech/Sci/R&D Officer | 53 | 22-02-27 |
Jacquelyn Sumer
CMP | Compliance Officer | 46 | 22-08-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | 17-07-31 | |
Thomas Ebeling
BRD | Director/Board Member | 65 | 17-07-31 |
Stephen Webster
BRD | Director/Board Member | 63 | 20-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.03% | 0 M€ | 0.00% | - | |
0.03% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 23.17 | -2.69% | 827,364 |
24-05-16 | 23.81 | -10.89% | 866,936 |
24-05-15 | 26.72 | +1.29% | 709,936 |
24-05-14 | 26.38 | +0.96% | 641,499 |
24-05-13 | 26.13 | -1.66% | 717,785 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+127.38% | 1.34B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- CGEM Stock